Received Oct 17, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | UNK | Z010429 | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | Z003402 | — |
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
No additional AE; Medical assistant reported that VAQTA and MMR II which underwent a temperature excursion were both administered to a patient; This spontaneous report was received from a healthcare professional regarding a patient of unknown age and gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported. On 08-OCT-2025, the patient was vaccinated with improperly stored doses of Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II), Injection 0.5 mL administered as prophylaxis (lot number reported as Z003402, which has been verified as valid, expiration date reported and validated as 23-JAN-2027) (vaccination scheme, route of administration, and anatomical site of injection were not reported), reconstituted with sterile diluent (Hollister-Stier STERILE DILUENT) (lot number and expiration date were not reported); and with Hepatitis A Vaccine, Inactivated (VAQTA) (lot number reported as Z010429, which has been verified as valid, expiration date reported and validated as 09-OCT-2026) 0.5 mL administered as prophylaxis (vaccination scheme, route of administration, and anatomical site of injection were not reported). The administered doses were exposed to a temperature excursion of 47.7 Fahrenheit degree (F) for 30 minutes (Product storage error). No symptoms were reported.